GOVERNMENT CONTRACT / PURCHASE ORDER
BISPECIFIC ANTIBODIES AGAINST CT-RCC HERV-E
Awarded to MYRIO THERAPEUTICS PTY LTD
$51.8K
Data last updated Oct 22, 2026 · Source: USAspending
- Company legal name
- MYRIO THERAPEUTICS PTY LTD
- UEI / CAGE
- ZNWKZF5TAEU2 / Not reported
- Parent award
- Not reported
- Awarding agency
- Department of Health and Human Services
- Subagency
- National Institutes of Health
- Industry
- Research & Science
- NAICS
- 541715
- PSC
- Q301
- Performance period
- Not reported — Not reported
- Recipient address
- 1/6-16 JOSEPH ST, BLACKBURN NORTH
- Place of performance
- Not reported
- Source last modified
- Nov 2, 2026
Derived from official transactions
Contract lifecycle
- Award announced
BISPECIFIC ANTIBODIES AGAINST CT-RCC HERV-E
Point-in-time model
Contract change outlook
Uncollapsed source history
Transactions and modifications
| Action date | Modification | Action type | Exact obligation | Current total | Potential total | Description | Source |
|---|---|---|---|---|---|---|---|
| Jan 18, 2024 | 0 | Not reported | $51,836.00 | Not reported | Not reported | BISPECIFIC ANTIBODIES AGAINST CT-RCC HERV-E | USAspending ↗ |